Pascale Salameh is an expert in Pharmacy at Charité - University Medicine Berlin (Germany). As of October 2026, ScienceLeadR ranks Pascale Salameh in the top 1% of experts worldwide for Epidemiologic Studies. Pascale Salameh has authored 842 publications, the most recent in 2026. SLR score: 2,696 (community average: 125). How the SLR is computed.

LeadR Profile

2 696 ScienceLeadR Reputation 2696
Network Map

Pharmacy

Subspecialties: Public Health - Immunology - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Pascale Salameh, PharmD, MPH, Ph.D., HDR, holds the position of full professor of Epidemiology at the Lebanese University, Faculty of Pharmacy, Lebanon, and is a senior researcher at the Fraunhofer Institute & Charité - Berlin. Additionally, she serves as an adjunct and visiting professor at esteemed institutions such as the Lebanese American University - School of Medicine and various European universities, including those in Germany, France, Belgium, and Cyprus. Proficient in research direction, accreditation, and education quality, she has extensive expertise in research design, data collection, management, and advanced statistical analysis.

Prof. Salameh ranks in the top 0.5% of global researchers in public health according to Scopus, with a remarkable portfolio comprising over 800 publications in peer-reviewed journals, numerous book chapters, and an extensive array of oral presentations and scientific posters. Her contributions span the fields of medical epidemiology, clinical pharmacy, higher education, and public health. Notably, she is the founder and director of INSPECT-LB, an autonomous multidisciplinary health research group recognized as the top-ranked institution in research by Scimago Institutional ranking for three consecutive years in Lebanon.

Prof. Salameh has been honored with the Medal of the French National Academy of Pharmacy and the prestigious Agence Universitaire Francophone Al Fassy lifetime award. She actively participates in various national committees related to health, leveraging her expertise as an antimicrobial resistance specialist collaborating with the World Health Organization in Geneva. Furthermore, she plays an integral role as an active member of the International Pharmaceutical Federation.

Prof. Salameh brings a wealth of administrative experience, having served as the Former Dean of the Faculty of Pharmacy at the Lebanese University and the Former Associate Dean for Academic Affairs at the School of Pharmacy at the Lebanese American University. She has also been the Chair of the Scientific Committee at the Lebanese Order of Pharmacists for many years, committing to advancing pharmacy through managing many pharmaceutical practice, education, and research projects.


Organizations

Career arc: 1998 - 2026

Source: PubMed

Lebanese University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 842

Citations

Citations: 12 925 1st author: 45 Last author: 344 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Harm reduction among refugees and displaced populations in Lebanon: a systematic review.
PMID 42894244 — gray literature, viruses, research, hepatitis, harm reduction
Harm Reduct J20260
Quality of life in patients with epilepsy in the context of socioeconomic challenges in Lebanon.
PMID 42859292 — quality of life, epilepsy, rehabilitation, therapeutics, health literacy, literacy
Qual Life Res20260
Medication adherence in epilepsy: Validation of the short medication adherence scale (SMAS-7) and mediation analysis of quality-of-life pathways.
PMID 42668596 — research design, quality of life, epilepsy, medication adherence, seizures, mediation analysis, mental health, negotiating
Explor Res Clin Soc Pharm20260
Reply to Sahrir Sillehu, Ilyas Ibrahim, and Muhammad Taufan Umasugi regarding 'Relationship between mindfulness and eHealth literacy: A cross-sectional study using validated scales'.
PMID 42659764 — cross-sectional studies, public health, mindfulness, literacy
Public Health20260
Dupilumab in Cholinergic Urticaria: An Exploratory Phase 2 Investigator-Initiated Study.
PMID 42538603 — hypersensitivity, urticaria, cholinergic agents
Allergy20260

LeadR Networks

Main global connection map